PATENT CLAIM ANALYSIS

Application Number: 16018924
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "254110"]

Abstract:
This invention provides compounds having the structure which may be used for the treatment of tumors.

Claim (Index 69):
The method of  claim 68  wherein the cancer that overexpresses N-CoR is glioblastoma multiforme.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 94.0
- Lexical Diversity: 1.0625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14328384', '12069147', '13866854', '13174249', '12460404']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8620850221607443
- 35 USC 102 Novelty (BERT): 0.5923144368184142
- Combined Prediction Score: 0.8351079636265113
- Mean Citation Score: 676.147648
- Max Citation Score: 739.547
- Similarity Product: 403.4612240211368

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test